Telomerase activity in plasma cell dyscrasias
Open Access
- 5 March 2001
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 84 (5) , 621-625
- https://doi.org/10.1054/bjoc.2000.1655
Abstract
Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research CampaignKeywords
This publication has 17 references indexed in Scilit:
- The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoterHuman Molecular Genetics, 1999
- Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.1998
- An Integrated Nanoliter DNA Analysis DeviceScience, 1998
- Telomerase activity and the expression of telomerase components in acute myelogenous leukaemiaBritish Journal of Haematology, 1998
- Multiple myeloma: increasing evidence for a multistep transformation process.1998
- Reconstitution of human telomerase activity in vitroCurrent Biology, 1998
- Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell linesNature Medicine, 1997
- Myeloma Bone Marrow Plasma Cells: Evidence for Their Capacity as Antigen-Presenting CellsBlood, 1997
- Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.1997
- Supression of telomerase activity in HL60 cells after treatment with differentiating agents.1996